CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz
Media Pack
News

Current Edition

Volume 18, Issue 2

Current Edition

Volume 18, Issue 2

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Advertisement

Nipro April 2026
News

Peli BioThermal Announces Availability of its New CoolPall™ Flex Bulk Shipper System

Peli BioThermal, the global name in temperature controlled packaging, has announced production of its newest addition to its range of bulk shippers, the CoolPall...
18 July 2018 News announces | availability
Continue Reading →
News

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive...
17 July 2018 News AbbVie | announces
Continue Reading →
News

CluePoints Announces Four Year Partnership with ONO Pharmaceutical and Strengthens RBM Position in Japan

CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has entered into a significant enterprise agr...
10 July 2018 News announces | cluepoints
Continue Reading →
News

PCI Pharma Services Announces Serialization Installation at Tredegar Manufacturing Center of Excellence

PCI’s Tredegar site is the latest site to offer full Serialization services to global customers     PCI Pharma Services (PCI) is pleased to anno...
25 June 2018 News announces | installation
Continue Reading →
News

FDA Announces Policies to Facilitate Development of Generic Drugs

Commissioner outlines new policies for drugs that have Risk Evaluation and Mitigation Strategy (REMS) requirements. In a recent statement, US Food and Drug Administr...
12 June 2018 News announces | development
Continue Reading →
News

Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma

DARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple mye...
8 May 2018 News announces | approval
Continue Reading →
News

HGF announces 2 new Partners

Dr Susan Keston HGF Ltd is delighted to announce that from the 1st of May 2018, Kieran Killough and Dr Susan Keston have been promoted to Partner, increasing...
1 May 2018 News announces | Dr Susan Keston
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026